MFM
LEXX icon

MD Financial Management’s Lexaria Bioscience LEXX Stock Holding History

MD Financial Management’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$11K Hold
2,686
– – ﹤0.01% 297
2021
Q3 		$17K Hold
2,686
– – ﹤0.01% 277
2021
Q2 		$23K Hold
2,686
– – ﹤0.01% 272
2021
Q1 		$15K Buy
+2,686
New +$15.7K ﹤0.01% 211

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EWM
Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
APC
Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

MD Financial Management's LEXX Position: Q4 2021 in Review

MD Financial Management held its Lexaria Bioscience (LEXX) position steady in Q4 2021 at 2,686 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #297.

MD Financial Management first reported a position in LEXX in Q1 2021 and has held it in 4 quarters since. The position peaked at $23K in Q2 2021. 13 funds tracked by Wall St. Rank hold LEXX as of Q4 2021.

  • MD Financial Management held 2,686 shares of Lexaria Bioscience worth $11K as of Q4 2021.
  • MD Financial Management left its Lexaria Bioscience share count unchanged in Q4 2021.
  • Lexaria Bioscience made up ﹤0.01% of MD Financial Management's portfolio in Q4 2021, its #297 holding.
  • MD Financial Management first reported a position in Lexaria Bioscience in Q1 2021 and has held it in 4 quarters since.
  • MD Financial Management's Lexaria Bioscience position peaked at $23K in Q2 2021.
  • 13 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q4 2021.

Based on MD Financial Management's 13F filing for Q4 2021, filed 14 Feb 2022.